tiprankstipranks
Hookipa Pharma Rises on Roche Deal
Market News

Hookipa Pharma Rises on Roche Deal

Shares of biopharmaceutical company Hookipa Pharma (NASDAQ:HOOK) are soaring today on the back of its licensing deal with Roche for HB-700 and a novel immunotherapy (undisclosed).

With this move, Hookipa gains an upfront payment of $25 million, a potential optional payment of $15 million for another candidate as well as milestone payments of up to $930 million (apart from sales royalties).

Shares are now up ~24.4% over the last five days.

Read full Disclosure

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles